Indian Journal of Rheumatology
Volume 6, Issue 2 , Pages 68-75 , June 2011

Indian rheumatology association guidelines for management of glucocorticoid-induced osteoporosis

  • Venkataraman Krishnamurthy

      Affiliations

    • Consultant Rheumatology, Apollo Speciality Hospital, Chennai & Meenakshi Multispecialty Hospital, Chennai
    • Corresponding Author InformationCorrespondence: Venkataraman Krishnamurthy
    • ,
  • Aman Sharma

      Affiliations

    • Assistant Professor (Rheumatology), Department of Internal Medicine, PGIMER, Chandigarh
    • ,
  • Amita Aggarwal

      Affiliations

    • Additional Professor, Department of Clinical Immunology, SGPGI, Lucknow
    • ,
  • Uma Kumar

      Affiliations

    • Additional Professor of Medicine Head, Clinical Immunology & Rheumatology, AIIMS, New Delhi
    • ,
  • Sanjiv Amin

      Affiliations

    • Consultant Rheumatology, Mumbai
    • ,
  • Uppuluri Ramakrishna Rao

      Affiliations

    • Director & Consultant Rheumatology, Sri Deepti Rheumatology Centre, Hyderabad
    • ,
  • Gumdal Narsimulu

      Affiliations

    • Professor & Head, Department of Rheumatology, Nizam's Institute of Medical Sciences, Hyderabad
    • ,
  • Rohini Handa

      Affiliations

    • Senior Consultant Rheumatologist, Apollo Indraprastha Hospitals, New Delhi
    • ,
  • Ambrish Mithal

      Affiliations

    • Chairman & HOD, Division of Endocrinology and Diabetes, Medanta, the Medicity, Mumbai
    • ,
  • Shashank Joshi

      Affiliations

    • Senior Consultant (Endocrinologist), Lilavati Hospital and Research Center, Mumbai

References 

  1. van Staa TP , Leufkens HGM , Abenhaim L , Zhang B , Cooper C . Use of oral corticosteroids and risk of fractures . J Bone Miner Res . 2000;15:993–1000
  2. Laan RFJM , van Riel PLCM , van de Putte LBA , van Erning LJTO , van't Hof MA , Lemmens JAM . Low-dose prednisolone induces rapid reversible axial bone loss in patients with rheumatoid arthritis . Ann Intern Med . 1993;119:963–968
  3. O'Brien CA , Jia D , Plotkin LI , Bellido T , Powers CC , Stewart SA , et al.   Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength . Endocrinology . 2004;145:1835–1841
  4. Cooper C , Coupland C , Mitchell M . Rheumatoid arthritis, corticosteroid therapy and hip fracture . Ann Rheum Dis . 1995;54:49–52
  5. van Rossum EF , Lamberts SW . Polymorphism in the gluco-corticosteroid receptor gene and their association with metabolic parameters and body composition . Recent Prog Horm Res . 2004;59:333–357
  6. Cummings SR , Melton LJ . Epidemiology and outcomes of osteoporotic fractures . Lancet . 2002;359:1761–1767
  7. Kannus P , Sievanen H , Palvanen M , et al.   Prevention of falls and consequent injuries in elderly people . Lancet . 2005;366:1885–1893
  8. Bischoff HA , Stahelin HB , Dick  , et al.   Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial . J Bone Min Res . 2003;18:343–351
  9. Fielding RA . The role of progressive resistance training and nutrition in the preservation of lean body mass in the elderly . J Am Coll Nutrition . 1995;14:587–594
  10. Duncan CS , Blimkie CJ , Cowell CT , et al.   Bone mineral density in adolescent female athletes: relationship to exercise type and muscle strength . Med Sci Sports Exercise . 2002;34:286–294
  11. Ziegler R , Kasperk C . Glucocorticoid-induced osteoporosis: prevention and treatment . Steroids . 1998;63:344–348
  12. Boonen S , Lips P , Bouillon R , et al.   Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta-analysis of randomized controlled trials . J Clinic Endo Metabol . 2007;92:1415–1423
  13. Zhu K , Devine A , Dick IM , et al.   Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a 5-year randomised controlled trial. Calcium and vitamin D prevents hip bone loss . J Clini Endo Metabol . 2008;93:743–749
  14. Boonen S , Bischoff-Ferrari A , Cooper C , et al.   Addressing the músculo skeletal components of fracture risk with calcium and vitamin D: a review of the evidence . Calcified Tissue International . 2006;78:257–270
  15. Dawson-Hughes B , Harris SS , Krall EA , et al.   Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women . Am J Clin Nutrition . 2000;72:745–750
  16. Boonen S , Dejaeger E , Vanderschueren D , et al.   Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective . Best Prac Res Clin Endocrinol Metabol . 2008;22:765–785
  17. Curhan GC , Willett WC , Rimm EB , et al.   A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones . N Engl J Med . 1993;328:833–838
  18. Bolland J , Avenell A , Baron J , et al.   Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis . BMJ . 2010;341:c3691
  19. Ziegler R , Kasperk C . Glucocorticoid-induced osteoporosis: prevention and treatment . Steroids . 1998;63:344–348
  20. Saigal R , Mathur Y , Prashant RK , et al.   Glucocorticoid-induced osteoporosis . Indian J Rheumatol . 2006;1:20–25
  21. Dickiel LJ , Church LD , Coulthard LR , et al.   Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes . Rheumatology . 2010;49:1466–1471
  22. Campbell IA , Douglas JG , Francis RM , Prescott RJ , Reid DM , On behalf of the Research Committee of the British Thoracic Society  . Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled Glucocorticoids . Thorax . 2004;59:761–768
  23. Ringe JD , Dorst A , Faber H , Ibach K , Preuss J . Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis . Rheumatology . 2003;42:743–749
  24. Reid DM , et al.   Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomized controlled trial . Lancet . 2009;373:1253–1263
  25. Cranney A , Welch Y , Adachi JD , Homik J , Shea B , Suarez-Almazor ME , et al.   Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis . Cochrane Database Syst Rev . 2000;CDOO1983
  26. Saag KG , Shane E , Boonen S , Marin F , Donley DW , Taylor KA , et al.   Teriperatide or alendronate in glucocorticoid-induced osteoporosis . N Engl J Med . 2007;357:2028–2039
  27. Reid IR , Wattie DJ , Evans MC , Stapleton JP . Testosterone therapy in glucocorticoid-treated men . Arch Intern Med . 1996;156:1173–1177
  28. Rudge S , Hailwood S , Home A , Lucas J , Wu F , Cundy T . Effects of once weekly oral alendronate on bone in children on glucocortcoid treatment . Rheumatology . 2005;44:813–818
  29. Grossman JM , Gordon R , Ranganath VK , Deal C , Caplan L , Chen W , et al.   American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid induced osteoporosis . Arthritis Care Res . 2010;62:1515–1526

 Endorsed by: Endocrine Society of India and Indian Society for Bone & Mineral Research

PII: S0973-3698(11)60060-5

doi: 10.1016/S0973-3698(11)60060-5

Indian Journal of Rheumatology
Volume 6, Issue 2 , Pages 68-75 , June 2011

Article Tools